Help ?

IGMIN: あなたがここにいてくれて嬉しいです. お願いクリック '新しいクエリを作成してください' 当ウェブサイトへの初めてのご訪問で、さらに情報が必要な場合は.

すでに私たちのネットワークのメンバーで、すでに提出した質問に関する進展を追跡する必要がある場合は, クリック '私のクエリに連れて行ってください.'

Subjects Content

Welcome to IgMin Research – an Open Access journal uniting Biology Group, Medicine Group, and Engineering Group. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Biology Group

The Biology Group explores diverse topics in life sciences, providing open access to cutting-edge research and fostering global collaboration in biological studies.

Medicine Group

The Medicine Group focuses on advancing medical knowledge through open access research, promoting innovation, and encouraging global collaboration in healthcare studies.

Engineering Group

The Engineering Group showcases cutting-edge research across engineering fields, providing open access and encouraging global collaboration and innovation.

General Science Group

The General Science Group covers a broad range of scientific disciplines, offering open access to research that drives innovation and fosters global collaboration.

Members Content

Our focus is on creating synergies between different scientific disciplines for faster knowledge gains.

Articles Content

Our focus is on creating synergies between different scientific disciplines for faster knowledge gains.

Identify Us

Our focus is on creating synergies between different scientific disciplines for faster knowledge gains.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
publications.support@igmin.org
E-Books Support
ebooks.support@igmin.org
Webinars & Conferences Support
webinarsandconference@igmin.org
Content Writing Support
contentwriting.support@igmin.org

Search

Explore Section

Content for the explore section slider goes here.

Abstract

要約 at IgMin Research

Our focus is on creating synergies between different scientific disciplines for faster knowledge gains.

Biology Group Research Article 記事ID: igmin175

LC-MS and HPLC-UV for Detecting Uremic Toxins: Two Validated Methods with Simultaneous Sensitivity and Specificity Evaluation

Molecular Biology Affiliation

Affiliation

    Biofordrug, Spin-off dell’Università degli Studi di Bari, via Dante 99, 70019, Triggiano, Bari, Italy

    Biofordrug, Spin-off dell’Università degli Studi di Bari, via Dante 99, 70019, Triggiano, Bari, Italy

要約

Uremic toxins (UTs) are compounds derived from the metabolism of dietary molecules such as tryptophan (Indossyl Sulphate, IS) and phenil-alanine (P-Cresyl Sulphate, PCS), that are normally eliminated by the kidneys of healthy patients. The accumulation of such toxins is an indicator of kidney disease at different degrees of severity, and the toxins can be found as free or protein bound in human biological samples. The toxicity of such compounds causes the loss of several biological functions, and the subjects suffering from such complications will need, more often than not, hemodialysis to properly excrete these toxins. Despite this not being a resolutive, but rather a symptom managing clinical approach, this is the most common course of treatment. Two analytical methods are proposed to quantify both the protein-bound and free forms of IS and PCS (HPLC-UV for the former; LC-MS/MS with ESI negative ionization for the latter), with lower variability and higher robustness than what is currently proposed, allowing for a precise simultaneous determination of the aforementioned UTs.

数字

参考文献

    1. Regunathan-Shenk R, Shah NB, Raj DS. Chapter 11-the gut microbiome and the kidney. Nutritional Management of Renal Disease (Fourth Edition). 2022; 147-161.
    2. Karadsheh FF, Weir MR. Chapter 23 - Hematologic Complications of Chronic Kidney Disease: Leukocyte and Monocyte Function, Hematologic Complications of Chronic Kidney Disease. Chronic Renal Disease. 2015; 277-284.
    3. Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745. PMID: 31573641; PMCID: PMC7015670.
    4. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31. Erratum in: Lancet. 2013 Jul 20;382(9888):208. PMID: 23727169.
    5. Falconi CA, Junho CVDC, Fogaça-Ruiz F, Vernier ICS, da Cunha RS, Stinghen AEM, Carneiro-Ramos MS. Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System. Front Physiol. 2021 May 14;12:686249. doi: 10.3389/fphys.2021.686249. PMID: 34054588; PMCID: PMC8160254.
    6. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W; European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. Erratum in: Kidney Int. 2020 Nov;98(5):1354. PMID: 12675874.
    7. Evenepoel P, Meijers BK, Bammens BR, Verbeke K. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009 Dec;(114):S12-9. doi: 10.1038/ki.2009.402. PMID: 19946322.
    8. Caldiroli L, Armelloni S, Eskander A, Messa P, Rizzo V, Margiotta E, Cesari M, Vettoretti S. Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease. Exp Gerontol. 2021 May;147:111266. doi: 10.1016/j.exger.2021.111266. Epub 2021 Jan 30. PMID: 33529747.
    9. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxin Work Group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009 Oct;4(10):1551-8. doi: 10.2215/CJN.03980609. Epub 2009 Aug 20. PMID: 19696217; PMCID: PMC2758258.
    10. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med. 1994 Jul;124(1):96-104. PMID: 8035108.
    11. Korytowska N, Wyczałkowska-Tomasik A, Pączek L, Giebułtowicz J. Evaluation of Salivary Indoxyl Sulfate with Proteinuria for Predicting Graft Deterioration in Kidney Transplant Recipients. Toxins (Basel). 2021 Aug 16;13(8):571. doi: 10.3390/toxins13080571. PMID: 34437442; PMCID: PMC8402605.
    12. Fabresse N, Larabi IA, Abe E, Lamy E, Rigothier C, Massy ZA, Alvarez JC. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers. Toxins (Basel). 2023 Feb 13;15(2):150. doi: 10.3390/toxins15020150. PMID: 36828466; PMCID: PMC9967652.
    13. Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl Sulfate. Toxins (Basel). 2017 Jan 29;9(2):52. doi: 10.3390/toxins9020052. PMID: 28146081; PMCID: PMC5331431.
    14. Pretorius CJ, McWhinney BC, Sipinkoski B, Johnson LA, Rossi M, Campbell KL, Ungerer JP. Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method. Clin Chim Acta. 2013 Apr 18;419:122-6. doi: 10.1016/j.cca.2013.02.008. Epub 2013 Feb 18. PMID: 23428591.
    15. Yousef Selim N, Farag Mannaa H, Atef Sharaki O, Zaytoun T, Elkholy N, Arafat W. Highlighting Levels of Indoxyl Sulphate among Critically Ill Patients with Acute Nephrotoxicity; Correlations Between Indoxyl Sulphate Levels and Patients' Characteristics. Rep Biochem Mol Biol. 2021 Jul;10(2):266-279. doi: 10.52547/rbmb.10.2.266. PMID: 34604416; PMCID: PMC8480295.
    16. Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA, Sandra P, Vanholder R. A novel UPLCMS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem. 2013; 405: 1937–1947.
    17. Lin CJ, Chen HH, Pan CF, Chuang CK, Wang TJ, Sun FJ, Wu CJ. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal. 2011;25(3):191-7. doi: 10.1002/jcla.20456. PMID: 21567467; PMCID: PMC6647585.
    18. Cuoghi A, Caiazzo M, Bellei E, Monari E, Bergamini S, Palladino G, Ozben T, Tomasi A. Quantification of p-cresol sulphate in human plasma by selected reaction monitoring. Anal Bioanal Chem. 2012 Oct;404(6-7):2097-104. doi: 10.1007/s00216-012-6277-z. Epub 2012 Aug 7. PMID: 22868475.

類似の記事

Efficacy of Different Concentrations of Insect Growth Regulators (IGRs) on Maize Stem Borer Infestation
Muhammad Salman Hameed, Khurshied Ahmed Khan, Nida Urooj and Ijaz Rasool Noorka
DOI10.61927/igmin147
Lifestyle and Well-being among Portuguese Firefighters
Laura Carmona, Raquel Pinheiro, Joana Faria-Anjos, Sónia Namorado and Maria José Chambel
DOI10.61927/igmin146
Solar Energy Resource Potentials of the City of Arkadag
Penjiyev Ahmet Myradovich and Orazov Parahat Orazmuhamedovich
DOI10.61927/igmin119
The Influence of Low Pesticide Doses on Fusarium Molds
Mihaela Ursan, Oana-Alina Boiu-Sicuia, Ioana Irina Crăinescu and Călina Petruța Cornea
DOI10.61927/igmin226

ソーシャルアイコン

研究を公開する

私たちは、科学、技術、工学、医学に関する幅広い種類の記事を編集上の偏見なく公開しています。

提出する

見る 原稿のガイドライン 追加 論文処理料

IgMin 科目を探索する
グーグルスカラー
welcome Image

Google Scholarは2004年11月にベータ版が発表され、幅広い学術領域を航海する学術ナビゲーターとして機能します。それは査読付きジャーナル、書籍、会議論文、論文、博士論文、プレプリント、要約、技術報告書、裁判所の意見、特許をカバーしています。 IgMin の記事を検索